Regional Blood-Inventory Coordination Director — Acute Care Network

The mandate

Hospitals, collection centres and processing laboratories maintain accurate local blood stocks, yet the region cannot reliably see usable inventory after compatibility, reservation, transport, expiry and quality hold. During surges, specialists coordinate by telephone because a nominal unit count can conceal antigen requirements, uncompleted testing or inaccessible location. The network needs a decision platform, not a central stock dashboard.

The deliverable is a Regional Blood Coordination Blueprint covering donation and component identity, test and release state, compatibility attributes, reservation, transfer, cold-chain evidence, expiry, return and emergency allocation. It will include reference journeys for routine redistribution, rare-component search and mass-casualty surge while preserving authorised clinical and blood-service decisions.

Milestone one at week four supplies clinical journeys, source gaps and decision-risk ranking. Week nine concludes milestone two with contracts, architecture and privacy boundaries. At week sixteen, milestone three delivers simulations across hospitals and the blood service. The accepted blueprint, operating playbook, supplier requirements and rollout economics form milestone four at week twenty-two.

Acceptance requires transfusion teams to locate and explain fifteen unseen usable units from collection through current disposition; transport and expiry changes must update availability correctly; and a surge exercise must allocate visibility without replacing clinical prioritisation. Medical and service sponsors sign only after internal coordinators manage a rare-component scenario without consultant interpretation.

The client will provide pseudonymised component records, testing and release states, hospital reservations, compatibility requirements, transport histories, temperatures, wastage, incidents and emergency plans. Blood-bank physicians, laboratory staff and transport teams will join tests. Client engineers build reference interfaces, while authorised clinicians retain transfusion and patient-allocation decisions.

Why this is external work

Each institution safely manages its own inventory, but no team can neutrally define regional availability and transfer obligations across legal and clinical boundaries. Inventory vendors count units without understanding compatibility and release nuance. External work can connect decision evidence, privacy and emergency continuity without centralising medical judgement.

What you will own

• Map donation, component, test, release, reservation, compatibility, transport, receipt, transfusion, return and expiry states regionally.
• Define component identity, effective status, custody, temperature, correction, acknowledgement and confidence contracts across institutions.
• Design usable-inventory views that preserve clinical attributes, quality holds and accessibility rather than displaying raw unit count.
• Exercise rare-component search, hospital refrigerator failure, delayed testing, transport disruption and mass-casualty demand.
• Establish privacy and access rules separating donor, component, patient and aggregate operational evidence appropriately.
• Model redistribution, emergency transport, reduced expiry and integration economics across different hospital sizes.
• Transfer simulation, contract change and regional coordination governance to blood-service and hospital owners.

Candidate qualifications

• Led production digital blood, transplant, laboratory or time-critical clinical supply platforms across several independent healthcare institutions.
• Modelled genuinely usable inventory through testing, compatibility, reservation, custody, transport, quality hold and expiry at decision time.
• Designed emergency coordination that informed scarce-component search but did not automate clinical allocation or transfusion decisions.
• Governed sensitive donor and patient information while preserving end-to-end traceability, haemovigilance and investigation evidence.
• Ran cross-hospital surge or rare-component exercises under real transport, staffing, cold-chain and laboratory constraints.
• Delivered vendor-neutral regional architecture and internal operating capability before a fixed seasonal or emergency-readiness milestone.

Non-negotiables

• The named director must work on site across Madrid hospitals, processing centres and coordination exercises.
• No commercial relationship may exist with blood-system, laboratory, cold-chain or logistics vendors under consideration.
• Clinical compatibility, component release and patient allocation remain with authorised medical and blood-service professionals.
• Donor and patient identifiers must be minimised and protected inside approved health-data environments.

1. 49 words maximum. Describe a blood unit that appeared available but was unusable because of compatibility, release or transport state.
2. 49 words maximum. How would you expose regional inventory without revealing unnecessary donor or patient information?
3. 49 words maximum. Which client inputs are essential before a rare-component surge exercise can be accepted?